Rutgers Cancer Institute, 195 Little Albany Street — New Brunswick, New Jersey

Rutgers Cancer Institute, 195 Little Albany Street is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Rutgers Cancer Institute, 195 Little Albany Street has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Sponsors: Philogen S.p.A..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers Cancer Institute, 195 Little Albany Street?

Rutgers Cancer Institute, 195 Little Albany Street has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers Cancer Institute, 195 Little Albany Street conducted?

Rutgers Cancer Institute, 195 Little Albany Street has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Is Rutgers Cancer Institute, 195 Little Albany Street accredited by Crixeo Health?

Rutgers Cancer Institute, 195 Little Albany Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutgers Cancer Institute, 195 Little Albany Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.